Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

SparX Biopharma to present phase 1 clinical updates of SPX-303, a dual checkpoint bispecific antibody, during AACR 2025: Chicago Monday, April 21, 2025, 16:00 Hrs [IST] SparX Biop ...

Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

Chronic lymphocytic leukemia (CLL) cell–derived exosomes demonstrated the ability to alter healthy donor cell function and ...

Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...